LifeNet Health(R) Unveils New Biomedical Spine Implant
* Reuters is not responsible for the content in this press release.
VIRGINIA BEACH, Va., March 3 /PRNewswire-USNewswire/ -- LifeNet Health, a leading allograft bio-implant company, unveils the VertiGraft VG1(R) Cervical Bio-implant. This product has been engineered for anterior cervical fusion surgery to treat neck pain and cervical pathologies. The new VG1(R) Cervical Bio-implant was co-developed by LifeNet Health and DePuy Spine(TM), and is exclusively represented in the U.S. by DePuy Spine. "VG1(R) Cervical is an exciting addition to our VertiGraft spine specialty bio-implant portfolio. Many surgery centers and hospitals do not have access to the ultra low-temperature freezers needed to store frozen allograft. VG1 Cervical is freeze-dried so it can be stored at room temperature giving our customers convenient, room-temperature storage combined with the very high quality standards they demand. This new VG1(R) Cervical bio-implant will meet the surgeon's needs and benefit the patient by making very high quality allograft bio-implants available to more hospitals and surgery centers," says Michael Hobert, LifeNet Health's VertiGraft Product Manager. LifeNet Health's CEO Rony Thomas states, "LifeNet Health's VertiGraft portfolio is setting the standard in spine specialty allograft bio-implants. Our research and development teams have engineered this implant to provide the patient and the surgeon with the bio-implants they need. We want to maximize the chances of successful transplantation and we are proud to be able to provide the VG1(R) Cervical bio-implant as a solution." LifeNet Health will exhibit the company's bio-implants at this year's American Academy of Orthopaedic Surgeons (AAOS) meeting, to be held in San Francisco March 5th through 8th. At AAOS, LifeNet Health will officially unveil the new VertiGraft VG1(R) Cervical. The LifeNet Health exhibit booth at the AAOS Annual Meeting in San Francisco will give surgeons a chance to learn more about LifeNet Health's product lines, its outstanding safety record and its unyielding commitment to quality. Since 1995, LifeNet Health has distributed 1 million bio-implants with no incidence of disease transmission linked to tissue screened and processed using LifeNet Health's proprietary Allowash XG(R) technology. "Surgeons can depend on us. We offer high-quality, safe bio-implants to save lives and restore health," adds Thomas. LifeNet Health, founded in 1982, is a full service biomedical tissue banking system and a leading non-profit organ and tissue donation agency whose mission is saving lives and restoring health. LifeNet Health provides recovery and processing services for musculoskeletal and cardiovascular tissues, distributing more than 250,000 biomedical implants every year to restore health to patients around the world. For additional information about LifeNet Health, visit http://www.accesslifenet.org. CONTACT: Dena Reynolds of LifeNet, 1-800-847-7831 SOURCE LifeNet Dena Reynolds of LifeNet, +1-800-847-7831
- Children's corpses in Korean ferry reveal desperate attempts to escape |
- Obama reassures Japan, other allies on China as Asia trip begins |
- Ukraine's leaders say have U.S. backing to take on 'aggressors' |
- Australia vows to keep searching to solve missing Malaysian plane mystery
- Search for MH370 reveals a military vulnerability for China